13th Annual Proteins & Antibodies Congress27 - 29 April 2020 | London, UK
Cutting edge discussions on protein & antibody engineering and development strategies, biotherapeutics discovery & development, biologics manufacturing and bioanalytics
The Proteins & Antibodies Congress includes...
Over 450 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions.
Over 80 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production & manufacturing.
PLUS:
- Roundtable & Panel Discussions
- Pre-Event Webinars
Agenda at a Glance
27 April 2019 – Day One (Kick-off Sessions)
- Protein Engineering, Expression, Design & Selection
- Bioanalysis: Characterisation, Stability Testing And Formulation Development
- Biotherapeutics: Discovery & Development – Oncology & Immuno-Oncology
28 April 2020 – Day Two
- Antibody Engineering, Screening, Design, Development
- ADC Engineering, Bioconjugates and Fusion Proteins
- Biotherapeutics: Discovery & Development – Oncology & Immuno-Oncology
29 April 2020 – Day Three
- Antibody Engineering, Development & Generation (Part 1) and Biotherapeutics: Discovery & Development–Non-Oncology Indications (Part 2)
- Bioanalysis: PKPD & Manufacturing
- Biotherapeutics: Discovery & Development – Non-Oncology Indications
